| Charles William Bell, CRNA | |
|
4021 Avenue B, Scottsbluff, NE 69361-4602 | |
| (308) 630-1380 | |
| (308) 630-1354 |
| Full Name | Charles William Bell |
|---|---|
| Gender | Male |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 9 Years |
| Location | 4021 Avenue B, Scottsbluff, Nebraska |
| Accepts Medicare Assignments | May be. He may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1154709806 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | 101309 (Nebraska) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Regional West Medical Center | Scottsbluff, NE | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Northstar Anesthesia Of Nebraska Llc | 2264857135 | 23 |
News Archive
Researchers have published a new study that suggests a signaling pathway called ROBO2 is a therapeutic target for kidney diseases, specifically kidney podocyte injury and glomerular diseases.
Lakes, rivers and some private wells are becoming saltier, largely thanks to high levels of road salt sprinkled on streets during winter. According to an article in Chemical & Engineering News, the weekly newsmagazine of the American Chemical Society, this situation could cause harm to wildlife and humans.
A big international study has identified a special gene that regulates bone density and bone strength. The gene can be used as a risk marker for fractures and opens up opportunities for preventive medicine against fractures.
Regulus Therapeutics Inc. announced today that the Company has received a $10 million equity investment from sanofi-aventis in connection with the landmark alliance the two companies entered into on June 21, 2010. The equity investment by sanofi-aventis further strengthens the balance sheet of Regulus, and with this investment sanofi-aventis becomes the third investor in Regulus, along with its founding companies Alnylam Pharmaceuticals, Inc. and Isis Pharmaceuticals, Inc..
Mayo Clinic researchers along with collaborators from Life Technologies are reporting on the application of a new approach for sequencing RNA to study cancer tumors. Their findings from a proof-of-principle study on oral carcinomas appear in the current issue of PLoS One, the online science journal.
› Verified 1 days ago
| Entity Name | Regional West Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1982718219 PECOS PAC ID: 1759285885 Enrollment ID: O20031120000963 |
News Archive
Researchers have published a new study that suggests a signaling pathway called ROBO2 is a therapeutic target for kidney diseases, specifically kidney podocyte injury and glomerular diseases.
Lakes, rivers and some private wells are becoming saltier, largely thanks to high levels of road salt sprinkled on streets during winter. According to an article in Chemical & Engineering News, the weekly newsmagazine of the American Chemical Society, this situation could cause harm to wildlife and humans.
A big international study has identified a special gene that regulates bone density and bone strength. The gene can be used as a risk marker for fractures and opens up opportunities for preventive medicine against fractures.
Regulus Therapeutics Inc. announced today that the Company has received a $10 million equity investment from sanofi-aventis in connection with the landmark alliance the two companies entered into on June 21, 2010. The equity investment by sanofi-aventis further strengthens the balance sheet of Regulus, and with this investment sanofi-aventis becomes the third investor in Regulus, along with its founding companies Alnylam Pharmaceuticals, Inc. and Isis Pharmaceuticals, Inc..
Mayo Clinic researchers along with collaborators from Life Technologies are reporting on the application of a new approach for sequencing RNA to study cancer tumors. Their findings from a proof-of-principle study on oral carcinomas appear in the current issue of PLoS One, the online science journal.
› Verified 1 days ago
| Entity Name | Northstar Anesthesia Of Nebraska Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1578187670 PECOS PAC ID: 2264857135 Enrollment ID: O20200810001420 |
News Archive
Researchers have published a new study that suggests a signaling pathway called ROBO2 is a therapeutic target for kidney diseases, specifically kidney podocyte injury and glomerular diseases.
Lakes, rivers and some private wells are becoming saltier, largely thanks to high levels of road salt sprinkled on streets during winter. According to an article in Chemical & Engineering News, the weekly newsmagazine of the American Chemical Society, this situation could cause harm to wildlife and humans.
A big international study has identified a special gene that regulates bone density and bone strength. The gene can be used as a risk marker for fractures and opens up opportunities for preventive medicine against fractures.
Regulus Therapeutics Inc. announced today that the Company has received a $10 million equity investment from sanofi-aventis in connection with the landmark alliance the two companies entered into on June 21, 2010. The equity investment by sanofi-aventis further strengthens the balance sheet of Regulus, and with this investment sanofi-aventis becomes the third investor in Regulus, along with its founding companies Alnylam Pharmaceuticals, Inc. and Isis Pharmaceuticals, Inc..
Mayo Clinic researchers along with collaborators from Life Technologies are reporting on the application of a new approach for sequencing RNA to study cancer tumors. Their findings from a proof-of-principle study on oral carcinomas appear in the current issue of PLoS One, the online science journal.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Charles William Bell, CRNA 4021 Avenue B, Scottsbluff, NE 69361-4602 Ph: (308) 630-1380 | Charles William Bell, CRNA 4021 Avenue B, Scottsbluff, NE 69361-4602 Ph: (308) 630-1380 |
News Archive
Researchers have published a new study that suggests a signaling pathway called ROBO2 is a therapeutic target for kidney diseases, specifically kidney podocyte injury and glomerular diseases.
Lakes, rivers and some private wells are becoming saltier, largely thanks to high levels of road salt sprinkled on streets during winter. According to an article in Chemical & Engineering News, the weekly newsmagazine of the American Chemical Society, this situation could cause harm to wildlife and humans.
A big international study has identified a special gene that regulates bone density and bone strength. The gene can be used as a risk marker for fractures and opens up opportunities for preventive medicine against fractures.
Regulus Therapeutics Inc. announced today that the Company has received a $10 million equity investment from sanofi-aventis in connection with the landmark alliance the two companies entered into on June 21, 2010. The equity investment by sanofi-aventis further strengthens the balance sheet of Regulus, and with this investment sanofi-aventis becomes the third investor in Regulus, along with its founding companies Alnylam Pharmaceuticals, Inc. and Isis Pharmaceuticals, Inc..
Mayo Clinic researchers along with collaborators from Life Technologies are reporting on the application of a new approach for sequencing RNA to study cancer tumors. Their findings from a proof-of-principle study on oral carcinomas appear in the current issue of PLoS One, the online science journal.
› Verified 1 days ago
Mr. Jon B. Nickell, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 2 W 42nd St, Suite 1500, Scottsbluff, NE 69361 Phone: 308-635-7362 | |
Thomas J Dredla Iii, CRNA Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 4021 Avenue B, Scottsbluff, NE 69361 Phone: 308-641-1311 Fax: 308-630-1656 | |
Chad Aaron Bagley, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 4021 Avenue B, Scottsbluff, NE 69361 Phone: 308-635-3711 | |
Mr. Jared Dean Workman, CRNA Nurse Anesthetist - CR Medicare: May Accept Medicare Assignments Practice Location: 4021 Avenue B, Scottsbluff, NE 69361 Phone: 308-635-3711 | |
Jessica L Wiedman, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 329 W 40th St, Scottsbluff, NE 69361 Phone: 308-635-3911 Fax: 308-635-3130 | |
Cindy R Braman, CRNA Nurse Anesthetist - CR Medicare: May Accept Medicare Assignments Practice Location: Two West 42nd St, Scottsbluff, NE 69361 Phone: 308-635-7362 Fax: 308-635-0426 |